Spatial distributions of cholinergic impairment and neuronal hypometabolism differ in MCI due to AD.


Journal

NeuroImage. Clinical
ISSN: 2213-1582
Titre abrégé: Neuroimage Clin
Pays: Netherlands
ID NLM: 101597070

Informations de publication

Date de publication:
2019
Historique:
received: 08 02 2019
revised: 24 07 2019
accepted: 08 08 2019
pubmed: 20 8 2019
medline: 22 9 2020
entrez: 19 8 2019
Statut: ppublish

Résumé

Elucidating the relationship between neuronal metabolism and the integrity of the cholinergic system is prerequisite for a profound understanding of cholinergic dysfunction in Alzheimer's disease. The cholinergic system can be investigated specifically using positron emission tomography (PET) with [

Identifiants

pubmed: 31422337
pii: S2213-1582(19)30328-6
doi: 10.1016/j.nicl.2019.101978
pmc: PMC6706587
pii:
doi:

Substances chimiques

Acetates 0
N-methyl-4-piperidyl acetate 0
Piperidines 0
Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D
Acetylcholinesterase EC 3.1.1.7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

101978

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Références

Neuroimage. 2009 Jan 1;44(1):83-98
pubmed: 18501637
Sci Transl Med. 2011 Nov 30;3(111):111cm33
pubmed: 22133718
Neuroimage. 2014 May 15;92:381-97
pubmed: 24530839
Curr Geriatr Rep. 2018 Mar;7(1):1-11
pubmed: 29503795
Alzheimers Res Ther. 2014 Jul 03;6(4):37
pubmed: 25024750
Stud Health Technol Inform. 2000;77:195-9
pubmed: 11187541
Neurobiol Aging. 2012 May;33(5):867-77
pubmed: 20961662
Rinsho Shinkeigaku. 1984 Nov;24(11):1128-35
pubmed: 6518703
J Nucl Med. 1995 Jul;36(7):1238-48
pubmed: 7790950
Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2249-2256
pubmed: 29026951
N Engl J Med. 2012 Aug 30;367(9):795-804
pubmed: 22784036
Hum Brain Mapp. 2002 Jan;15(1):1-25
pubmed: 11747097
Acta Neuropathol. 2015 Apr;129(4):527-40
pubmed: 25633602
Biochim Biophys Acta. 2012 Mar;1822(3):380-5
pubmed: 22115832
Eur J Nucl Med Mol Imaging. 2012 Apr;39(4):613-20
pubmed: 22270508
Brain. 2018 Jun 1;141(6):1840-1854
pubmed: 29672680
Cell Rep. 2018 Jul 3;24(1):38-46
pubmed: 29972789
BMC Nucl Med. 2006 Jul 12;6:4
pubmed: 16836759
J Nucl Med. 2011 Feb;52(2):173-9
pubmed: 21233181
Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
J Cereb Blood Flow Metab. 2010 Jan;30(1):2-14
pubmed: 19738630
Nuklearmedizin. 2011;50(2):74-82
pubmed: 21286660
Neuroimage Clin. 2016 Oct 08;14:77-86
pubmed: 28138429
Neuroimage Clin. 2014 Nov 18;7:34-42
pubmed: 25610765
Eur J Nucl Med. 1999 Feb;26(2):135-43
pubmed: 9933347
Dement Geriatr Cogn Disord. 1998;9 Suppl 2:20-6
pubmed: 9718231
J Cereb Blood Flow Metab. 2017 Feb;37(2):740-749
pubmed: 27107028
Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1700-9
pubmed: 27026271
Brain. 2018 Jul 1;141(7):1917-1933
pubmed: 29850777
Med Image Anal. 2001 Jun;5(2):143-56
pubmed: 11516708
J Neurochem. 1987 Jun;48(6):1845-50
pubmed: 3572402
Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2073-2083
pubmed: 28785843
Brain. 2018 Mar 1;141(3):903-915
pubmed: 29309600
Neuroimage. 1999 Feb;9(2):179-94
pubmed: 9931268
Neurobiol Aging. 2017 May;53:27-35
pubmed: 28208063
Nat Commun. 2016 Nov 04;7:13249
pubmed: 27811848
Neuroimage. 2002 Oct;17(2):825-41
pubmed: 12377157
Philos Trans R Soc Lond B Biol Sci. 2001 Aug 29;356(1412):1293-322
pubmed: 11545704
Alzheimer Dis Assoc Disord. 1995 Spring;9(1):6-16
pubmed: 7605624
Mol Psychiatry. 2017 Nov;22(11):1531-1538
pubmed: 28894304
Ann Neurol. 1997 Jul;42(1):85-94
pubmed: 9225689
Pharmacol Res. 2018 Apr;130:331-365
pubmed: 29458203
Neurology. 2012 May 15;78(20):1576-82
pubmed: 22551733
Lancet Neurol. 2010 Jan;9(1):119-28
pubmed: 20083042
Cereb Cortex. 2016 Jun;26(6):2411-2426
pubmed: 25840425
Schizophr Res. 2006 Apr;83(2-3):155-71
pubmed: 16448806
Lancet Neurol. 2015 Oct;14(10):1037-53
pubmed: 26318837
Alzheimer Dis Assoc Disord. 2000;14 Suppl 1:S114-8
pubmed: 10850739
Eur J Nucl Med. 1994 Oct;21(10):1052-60
pubmed: 7828614
Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):526-36
pubmed: 26555082
Neuron. 2002 Jan 31;33(3):341-55
pubmed: 11832223
J Neural Transm (Vienna). 2000;107(12):1457-68
pubmed: 11458998
Neuroimage. 2004;23 Suppl 1:S69-84
pubmed: 15501102

Auteurs

Nils Richter (N)

Department of Neurology, University Hospital Cologne, 50937 Cologne, Germany; Cognitive Neuroscience, Institute of Neuroscience and Medicine (INM-3), Research Center Jülich, 52425 Jülich, Germany; Max-Planck-Institute for Metabolism Research, 50937 Cologne, Germany. Electronic address: n.richter@fz-juelich.de.

Nils Nellessen (N)

Department of Neurology, University Hospital Cologne, 50937 Cologne, Germany; Cognitive Neuroscience, Institute of Neuroscience and Medicine (INM-3), Research Center Jülich, 52425 Jülich, Germany.

Julian Dronse (J)

Department of Neurology, University Hospital Cologne, 50937 Cologne, Germany; Cognitive Neuroscience, Institute of Neuroscience and Medicine (INM-3), Research Center Jülich, 52425 Jülich, Germany.

Kim Dillen (K)

Cognitive Neuroscience, Institute of Neuroscience and Medicine (INM-3), Research Center Jülich, 52425 Jülich, Germany.

Heidi I L Jacobs (HIL)

Cognitive Neuroscience, Institute of Neuroscience and Medicine (INM-3), Research Center Jülich, 52425 Jülich, Germany; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, United States of America; The Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, United States of America; Faculty of Health, Medicine and Life Sciences, School for Mental Health and Neuroscience, Alzheimer Centre Limburg, Maastricht University, Maastricht, the Netherlands.

Karl-Josef Langen (KJ)

Medical Imaging Physics (INM-4), Institute of Neuroscience and Medicine (INM-4), Research Center Jülich, 52425 Jülich, Germany.

Markus Dietlein (M)

Department of Nuclear Medicine, University Hospital Cologne, 50937 Cologne, Germany.

Lutz Kracht (L)

Max-Planck-Institute for Metabolism Research, 50937 Cologne, Germany; Department of Nuclear Medicine, University Hospital Cologne, 50937 Cologne, Germany.

Bernd Neumaier (B)

Institute for Radiochemistry and Experimental Molecular Imaging, University Hospital Cologne, 50937 Cologne, Germany; Nuclear Chemistry, Institute of Neuroscience and Medicine (INM-5), Research Center Jülich, 52425 Jülich, Germany.

Gereon R Fink (GR)

Department of Neurology, University Hospital Cologne, 50937 Cologne, Germany; Cognitive Neuroscience, Institute of Neuroscience and Medicine (INM-3), Research Center Jülich, 52425 Jülich, Germany.

Juraj Kukolja (J)

Cognitive Neuroscience, Institute of Neuroscience and Medicine (INM-3), Research Center Jülich, 52425 Jülich, Germany; Department of Neurology and Neurophysiology, Helios University Hospital Wuppertal, 42283 Wuppertal, Germany.

Oezguer A Onur (OA)

Department of Neurology, University Hospital Cologne, 50937 Cologne, Germany; Cognitive Neuroscience, Institute of Neuroscience and Medicine (INM-3), Research Center Jülich, 52425 Jülich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH